Ausgabe 3/2020
Inhalt (16 Artikel)
Adjuvant chemotherapy in endometrial cancer
César Gómez-Raposo, María Merino Salvador, Cristina Aguayo Zamora, Enrique Casado Saenz
Population pharmacokinetic modeling of PF-06439535 (a bevacizumab biosimilar) and reference bevacizumab (Avastin®) in patients with advanced non-squamous non-small cell lung cancer
Cheryl S. W. Li, Kevin Sweeney, Carol Cronenberger
Characterization of infections and hypogammaglobulinemia treated with the combination of pertuzumab and trastuzumab
Joanne E. Mortimer, Laura Kruper, Jae Jung, Louise Wong, Jill Cooper, Daphne Stewart, Samuel Chung, Kim Wai Yu, Sanjeet Dadwal, Yuan Yuan
A retrospective study of the correlation of in vitro chemosensitivity using ATP-TCA with patient clinical outcomes in acute myeloid leukemia
Fan Xia, Sheng Ma, Yicong Bian, Di Yu, WenXia Ma, Miao Miao, Chenrong Huang, Liyan Miao
Interstitial lung disease in advanced pancreatic ductal adenocarcinoma patients treated with gemcitabine and nab-paclitaxel combination therapy: a retrospective analysis
Hiroki Irie, Rei Suzuki, Tadayuki Takagi, Mitsuru Sugimoto, Naoki Konno, Yuki Sato, Takuto Hikichi, Jun Nakamura, Minami Hashimoto, Hiromasa Ohira
Blood mRNA expression of REV3L and TYMS as potential predictive biomarkers from platinum-based chemotherapy plus pemetrexed in non-small cell lung cancer patients
M. Teresa Agulló-Ortuño, Inmaculada García-Ruiz, C. Vanesa Díaz-García, Ana B. Enguita, Virginia Pardo-Marqués, Elena Prieto-García, Santiago Ponce, Lara Iglesias, Jon Zugazagoitia, José A. López-Martín, Luis Paz-Ares, Juan A. Nuñez
Preoperative chemoradiotherapy using gemcitabine for pancreatic ductal adenocarcinoma in patients with impaired renal function
Yoshito Tomimaru, Hidetoshi Eguchi, Yoshifumi Iwagami, Hirofumi Akita, Takehiro Noda, Kunihito Gotoh, Shogo Kobayashi, Hiroaki Nagano, Masaki Mori, Yuichiro Doki
The influence of single-nucleotide polymorphisms on overall survival and toxicity in cabazitaxel-treated patients with metastatic castration-resistant prostate cancer
Bodine P. S. Belderbos, Mirjam de With, Rajbir K. Singh, Bram C. Agema, Samira El Bouazzaoui, Esther Oomen-de Hoop, Ronald de Wit, Ron H. N. van Schaik, Ron H. J. Mathijssen, Sander Bins
A randomized, double-blind, single-dose study to evaluate the biosimilarity of QL1101 with bevacizumab in healthy male subjects
Ya-nan Liu, Jie Huang, Can Guo, Shuang Yang, Ling Ye, Shu-ting Wu, Xing-fei Zhang, Xiao-yan Yang, Cui-cui Han, Qi Pei, Lu Huang, Qing-nan He, Guo-ping Yang
Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats
Mohammad Sheibani, Sadaf Nezamoleslami, Hedyeh Faghir-Ghanesefat, Amir hossein Emami, Ahmad Reza Dehpour
The use of Trichomonas vaginalis purine nucleoside phosphorylase to activate fludarabine in the treatment of solid tumors
William B. Parker, Paula W. Allan, William R. Waud, Jeong Hong, Melissa Gilbert-Ross, B. R. Achyut, Disha Joshi, Turang Behbahani, Regina Rab, Steven E. Ealick, Eric J. Sorscher
Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance
Melanie White-Koning, Marie Noëlle Paludetto, Félicien Le Louedec, Laurence Gladieff, Christine Chevreau, Etienne Chatelut, Florent Puisset
A Phase I dose-escalation, pharmacokinetics and food-effect study of oral donafenib in patients with advanced solid tumours
Xiaoyu Li, Meng Qiu, ShengJun Wang, Hong Zhu, Bi Feng, Li Zheng
Evaluation of gefitinib systemic exposure in EGFR-mutated non-small cell lung cancer patients with gefitinib-induced severe hepatotoxicity
Takahisa Kawamura, Chiyo K. Imamura, Hirotsugu Kenmotsu, Tetsuhiko Taira, Shota Omori, Kazuhisa Nakashima, Kazushige Wakuda, Akira Ono, Tateaki Naito, Haruyasu Murakami, Taisei Mushiroda, Toshiaki Takahashi, Yusuke Tanigawara
Relationship between vemurafenib plasma concentrations and survival outcomes in patients with advanced melanoma
Ganessan Kichenadasse, Jim Henry Hughes, John O. Miners, Arduino A. Mangoni, Andrew Rowland, Ashley M. Hopkins, Michael J. Sorich
Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer
Hani M. Babiker, Mohammed Milhem, Joseph Aisner, William Edenfield, Dale Shepard, Michael Savona, Swaminathan Iyer, Maen Abdelrahim, C. L. Beach, Barry Skikne, Eric Laille, Kao-Tai Tsai, Thai Ho